In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Cigna’s current price of $269.74 is significantly below the PERT-weighted fair value of $1,048.34, indicating substantial upside potential with high confidence. Monte Carlo analysis shows zero downside risk below the current price, despite high volatility and a wide value range. Financial health is fair, with strong profitability but weaker liquidity and growth metrics, implying moderate operational risk amid strong valuation opportunity.